Abstract:Peripheral inflammation induces central sensitization characterized by the development of allodynia and hyperalgesia to thermal stimuli. Recent evidence suggests that activation of glial cells and a subsequent increase in proinflammatory cytokines contribute to the development of behavioral hypersensitivity after nerve injury or peripheral inflammation. The neuropeptide nociceptin/orphanin FQ (N/OFQ), the endogenous agonist of the N/OFQ peptide receptor (ORL1 receptor), has been demonstrated to play an important role in modulation of nociceptive signals. In the present study, we investigated: (1) astrocyte activation and proinflammatory cytokine expression at the lumbar spinal cord following intraplantar administration of complete Freund’s adjuvant (CFA) in rats; (2) the mechanism of N/OFQ on nociception modulation, the relationship between N/OFQ and cytokines in the rat CNS in vivo and in vitro. The results showed: (1) CFA-induced peripheral inflammation evoked robust astrocyte activation and proinflammatory cytokines spinally; (2) down-regulation of cytokine mRNA transcripts by intrathecal administration of N/OFQ, the effects produced by N/OFQ were abolished by combination with ORL1 receptor-specific antagonist [Nphe1]N/OFQ(1–13)NH2; (3) ORL1 receptor was expressed on astrocytes of rat spinal cord; (4) cytokine gene expression was inhibited in astrocyte cultures exposed to N/OFQ, the inhibiting effects of N/OFQ were significantly blocked by [Nphe1]N/OFQ(1–13)NH2. The present data demonstrated that astrocyte activation and enhanced cytokine expression at the CNS had a role in eliciting behavioral hypersensitivity; the anti-nociception function of N/OFQ might be dependent on cytokines derived from astrocytes, the effects were attributable to the ORL1 receptor pathway.

Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells

Endogenous opioid receptor-like receptor in human neuroblastoma SK-N-SH cells: activation of inhibitory G protein and homologous desensitization

Functional expression, activation and desensitization of opioid receptor-like receptor ORL1 in neuroblastoma×glioma NG108-15 hybrid cells

Molecular Characterization and Functional Expression of Opioid Receptor-Like1 Receptor

Nociceptin/orphanin FQ Stimulates Extracellular Acidification and Desensitization of the Response Involves Protein Kinase C

Endotoxin Inhibits Orphan Opioid Receptor Gene Expression in Peripheral Blood Lymphocyte

Attenuation of nociceptin/orphanin FQ-induced signaling by N-methyl-D-aspartate in neuronal cells.

Endogenous δ-Opioid and ORL1 Receptors Couple to Phosphorylation and Activation of p38 MAPK in NG108-15 Cells and This Is Regulated by Protein Kinase A and Protein Kinase C

Nociceptin/Orphanin FQ activates protein kinase C, and this effect is mediated through phospholipase C/Ca2+ pathway

Involvement of ORL1 receptor and ERK kinase in the orphanin FQ-induced nociception in the nucleus accumbens of rats.

Orphanin FQ/nociceptin modulates glutamate- and kainic acid-induced currents in acutely isolated rat spinal dorsal horn neurons

Expression of ORL1 Mrna in Some Brain Nuclei in Neuropathic Pain Rats

Regulation of proinflammatory cytokines gene expression by nociceptin/orphanin FQ in the spinal cord and the cultured astrocytes.

Evidence of the Synthesis of Opioid Receptor Like 1 Receptor in Nociceptinergic Neurons in Rat Brain Suggests the Existence of Autoreceptor: A Confocal Double Staining Study

Functional Expression of Opioid Receptor-Like Receptor and Its Endogenous Specific Agonist Nociceptin/orphanin FQ During Mouse Embryogenesis.

Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic

[Antagonistic Effect of Orphanin FQ on Morphine Analgesia in Rat Brain].

Development of a genetically-encoded sensor for probing endogenous nociceptin opioid peptide release

Etorphine Inhibits Cell Growth and Induces Apoptosis in SK-N-SH Cells: Involvement of Pertussis Toxin-Sensitive G Proteins

Effects of Orphanin FQ on Endomorphin-1 Induced Analgesia

The SK-N-AS human neuroblastoma cell line develops osteolytic bone metastases with increased angiogenesis and COX-2 expression